Skip to content

Effects of Structural Integration on Chest Wall Expansion Among COPD Patients

Effects of "The 10-Series of Structural Integration" on Chest Wall Expansion Among COPD Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07752420
Enrollment
52
Registered
2026-08-07
Start date
2026-09-01
Completion date
2026-12-30
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD (With - Without Rehabilitation)

Keywords

COPD, Structural Integration, Chest Wall Expansion, Pulmonary Rehabilitation

Brief summary

The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.

Interventions

OTHERStructural Integration with Conventional Pulmonary Rehabilitation

* Conventional pulmonary rehabilitation. * The complete 10-Series of Structural Integration, delivered by a certified Structural Integration practitioner/physiotherapist.

OTHERPulmonary Rehabilitation only

Participants receive only the conventional pulmonary rehabilitation program.

Sponsors

Green International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Clinically diagnosed stable COPD according to GOLD criteria * GOLD stage II or III * No acute exacerbation within the previous four weeks * Able to ambulate independently * Medically cleared to participate in pulmonary rehabilitation * Willing to provide written informed consent

Exclusion criteria

* Severe cardiovascular disease contraindicating exercise * Recent thoracic or abdominal surgery (\<6 months) * Rib fractures or severe chest wall deformity * Neurological disorders affecting mobility * Active malignancy * Severe osteoporosis with high fracture risk * Previous Structural Integration treatment within the last year

Design outcomes

Primary

MeasureTime frameDescription
Chest Wall ExpansionBefore the start and end of 10 weeksChest wall expansion will be measured using a flexible measuring tape at: * Axillary level * Xiphoid level * Lower thoracic level (10th rib) Measurements will be taken during maximal inspiration and maximal expiration. The difference (in centimeters) will be recorded. Three readings will be obtained at each level, and the average value will be used for analysis.

Countries

Pakistan

Contacts

CONTACTMohtishim Ahmed, MSPT, DPT
mohtishim.ahmed@giu.edu.pk+923224057371

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026